Neurocrine Biosciences (NBIX) Profit After Tax (2016 - 2021)
Historic Profit After Tax for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $22.5 million.
- Neurocrine Biosciences' Profit After Tax rose 13906.25% to $22.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $444.8 million, marking a year-over-year increase of 37623.13%. This contributed to the annual value of $407.3 million for FY2020, which is 100081.08% up from last year.
- Per Neurocrine Biosciences' latest filing, its Profit After Tax stood at $22.5 million for Q3 2021, which was up 13906.25% from $42.3 million recorded in Q2 2021.
- In the past 5 years, Neurocrine Biosciences' Profit After Tax registered a high of $347.9 million during Q4 2020, and its lowest value of -$102.1 million during Q1 2019.
- For the 5-year period, Neurocrine Biosciences' Profit After Tax averaged around $22.1 million, with its median value being $22.5 million (2021).
- Per our database at Business Quant, Neurocrine Biosciences' Profit After Tax plummeted by 30659.26% in 2017 and then skyrocketed by 96757.99% in 2019.
- Over the past 5 years, Neurocrine Biosciences' Profit After Tax (Quarter) stood at $6.9 million in 2017, then soared by 162.23% to $18.1 million in 2018, then skyrocketed by 88.07% to $34.0 million in 2019, then skyrocketed by 923.24% to $347.9 million in 2020, then plummeted by 93.53% to $22.5 million in 2021.
- Its Profit After Tax was $22.5 million in Q3 2021, compared to $42.3 million in Q2 2021 and $32.1 million in Q1 2021.